Roy Austin - Living Cell Independent Chairman of the Board
| LVCLY Stock | USD 0.05 0.01 25.00% |
Chairman
Mr. Roy James Austin, BCom, CA, was Independent Chairman of the Board of Living Cell Technologies Ltd. Mr. Austin is a consultant to investment banking firm Northington Partners in New Zealand. He brings considerable commercial depth to the LCT Board with over 25 years investment transaction experience across multiple sectors including healthcare and biotechnology. His experience includes capital raisings, mergers and acquisitions, IP commercialization, VC and international business development. Mr. Austin is Chairman of New Zealand based Cure Kids, child health research charitable trust and its commercial biotech VC fund, Cure Kids Ventures Limited. He holds a number of other directorships in private companies, and is a member of the New Zealand Institute of Directors and the New Zealand Institute of Chartered Accountants. He was appointed to the board on February 25, 2011. Mr. Austin became the Acting Chairman of the Board. He is the Chairman of the Remuneration Nomination Committees and a member of the Audit Risk Compliance Committees.
| Phone | 61 3 8689 9997 |
| Web | https://www.lctglobal.com |
Living Cell Management Efficiency
The company has return on total asset (ROA) of (0.3084) % which means that it has lost $0.3084 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7233) %, meaning that it generated substantial loss on money invested by shareholders. Living Cell's management efficiency ratios could be used to measure how well Living Cell manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 1 records | CHAIRMAN Age | ||
| Abe Schwartz | Covalon Technologies | N/A | |
Management Performance
| Return On Equity | -0.72 | |||
| Return On Asset | -0.31 |
Living Cell Technologies Leadership Team
Elected by the shareholders, the Living Cell's board of directors comprises two types of representatives: Living Cell inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Living. The board's role is to monitor Living Cell's management team and ensure that shareholders' interests are well served. Living Cell's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Living Cell's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Belinda Bartolo, Chief Officer | ||
| Bus FCIS, Company Sec | ||
| Robert Elliott, Chief Science and Medical Officer | ||
| Mark Licciardo, Company Secretary | ||
| BSc BSc, Interim Officer | ||
| Roy Austin, Independent Chairman of the Board | ||
| Elizabeth McGregor, Joint Company Secretary | ||
| Carolyn Sue, Non-Executive Director | ||
| John Cowan, Head of Fin. and Admin. | ||
| Laurie Hunter, Independent Director | ||
| Bernie Tuch, Interim Chairman of the Board | ||
| Bernard Tuch, Independent Director | ||
| Ken Taylor, Acting CEO | ||
| Daya Uka, Chief Officer | ||
| Robert Willcocks, Independent Director |
Living Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Living Cell a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.72 | |||
| Return On Asset | -0.31 | |||
| Operating Margin | (428.70) % | |||
| Current Valuation | 12.53 M | |||
| Shares Outstanding | 128.54 M | |||
| Price To Earning | (31.35) X | |||
| Price To Book | 3.53 X | |||
| Price To Sales | 3,567 X | |||
| Revenue | 3.4 K | |||
| Gross Profit | 3.4 K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Living Cell in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Living Cell's short interest history, or implied volatility extrapolated from Living Cell options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Living Cell Technologies. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Living OTC Stock analysis
When running Living Cell's price analysis, check to measure Living Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Living Cell is operating at the current time. Most of Living Cell's value examination focuses on studying past and present price action to predict the probability of Living Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Living Cell's price. Additionally, you may evaluate how the addition of Living Cell to your portfolios can decrease your overall portfolio volatility.
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |